About Stevanato Group SpA 
Stevanato Group SpA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 45 Schemes (49.31%)
Foreign Institutions
Held by 71 Foreign Institutions (20.41%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
320 Million
(Quarterly Results - Mar 2026)
Net Profit:
33 Million
Pharmaceuticals & Biotechnology
USD 3,666 Million (Small Cap)
24.00
NA
0.00%
0.22
8.61%
2.10






